The grant to Indiana University scientists will address the large gap in knowledge about how marijuana affects the brain.
An IU researcher and colleagues will explore how the use of prescribed opioids for pain treatment during pregnancy affects offspring.
IU psychologists have found that when it comes to adopting a dog, what people say they want isn't always in line with what they choose.
Led by IU scientists, brainlife.io manages all aspects of research where people are more likely than machines to produce mistakes.
IU Distinguished Professor Linda Smith has been honored for lifetime achievement by the Society of Experimental Psychologists.
Projects must be directly related to moving IU research or scholarly activity closer to commercialization.
IU social psychologists have found that professors' beliefs about intelligence play a measurable role in the success of students in STEM.
In a sweeping new analysis, IU psychologists found that the apps can change thought patterns and behaviors related to depression.
The awards will honor researchers from across the U.S. conducting cutting-edge research on neuronal circuits.
IU researchers have found early evidence that microRNA could potentially act as biomarker for dementia.
Computer scientists, neuroscientists and psychologists came together for a unique gathering at IU Bloomington.
The ability to test human types of memory in animals will strengthen the search for drugs to treat Alzheimer's disease.
Researchers from across the globe will attend BrainHack Global 2018 at IU Bloomington to work on projects related to neuroscience.
Indiana University has received a $1.5 million gift to establish the endowed Naus Family Chair in Psychological and Brain Sciences.
IU researchers found football players' brain activity differs from athletes who play sports with a lower risk for subconcussions.
Chen Yu was awarded the NIH grant to study where infants look at the moment their parent names an object during early-stage development.
The former IU Bloomington chancellor, professor emerita and renowned scholar, died March 30, 2018, from complications of Alzheimer's disease.
An IU study suggests a compound proven safe for use in people could help reduce pain and prevent symptoms that can lead to opioid addiction.
Her history intersects with some of the most iconic people, places and events of African American history.
Professor Sharlene Newman said the study shines a spotlight on glutamate levels as a possible target for new therapies to treat addiction.